
OSR Holdings, Inc. — Investor Relations & Filings
OSR Holdings, Inc. is a healthcare holding company that operates using a hub-and-spoke model to manage a diverse portfolio of subsidiary companies. The company's vision is to accelerate healthcare innovation to improve health and wellness outcomes. It actively evaluates and pursues merger and acquisition opportunities that advance innovative healthcare, either by addressing unmet patient needs or by lowering patient costs and burden. The firm's development activities are focused on a portfolio of therapies and healthcare solutions, including oral immunotherapies for cancer treatment, design-augmented biologics, therapeutic antibodies, and engineered proteins.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| CURRENT REPORT | 2026-06-02 | English | |
| PROXY STATEMENT | 2026-05-26 | English | |
| 10-Q - OSR Holdings, Inc. (0001840425) (Filer) | 2026-05-13 | English | |
| 8-K/A - OSR Holdings, Inc. (0001840425) (Filer) | 2026-05-06 | English | |
| 8-K - OSR Holdings, Inc. (0001840425) (Filer) | 2026-04-30 | English | |
| 8-K - OSR Holdings, Inc. (0001840425) (Filer) | 2026-04-22 | English |
Browse filings by year
6 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
11 filings
| |||||
| 47937235 | CURRENT REPORT | 2026-06-02 | English | ||
| 47073266 | PROXY STATEMENT | 2026-05-26 | English | ||
| 45603271 | 10-Q - OSR Holdings, Inc. (0001840425) (Filer) | 2026-05-13 | English | ||
| 42032938 | 8-K/A - OSR Holdings, Inc. (0001840425) (Filer) | 2026-05-06 | English | ||
| 39151751 | 8-K - OSR Holdings, Inc. (0001840425) (Filer) | 2026-04-30 | English | ||
| 35420934 | 8-K - OSR Holdings, Inc. (0001840425) (Filer) | 2026-04-22 | English | ||
| 33910620 | 8-K - OSR Holdings, Inc. (0001840425) (Filer) | 2026-04-09 | English | ||
| 33256646 | 8-K/A - OSR Holdings, Inc. (0001840425) (Filer) | 2026-04-03 | English | ||
| 33191238 | 8-K - OSR Holdings, Inc. (0001840425) (Filer) | 2026-04-02 | English | ||
| 32013135 | 8-K Filing | 2026-01-27 | English | ||
| 13362203 | CURRENT REPORT | 2026-01-14 | English | ||
|
2025
4 filings
| |||||
| 13362205 | CURRENT REPORT | 2025-11-25 | English | ||
| 13362204 | QUARTERLY REPORT | 2025-11-12 | English | ||
| 13362206 | Director's Dealing 2025 | 2025-10-24 | English | ||
| 13362208 | CURRENT REPORT | 2025-10-16 | English | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
ACROBIOSYSTEMS CO.,LTD.
Provides recombinant proteins and reagents for life science…
|
301080 | CN | Professional, scientific and te… |
|
ACTINOGEN MEDICAL LIMITED
Developing cortisol-inhibiting therapies for Alzheimer's an…
|
ACW | AU | Professional, scientific and te… |
|
Active Biotech
Biotechnology company developing drugs for oncology and inf…
|
ACTI | SE | Professional, scientific and te… |
|
Adagene Inc.
Clinical-stage biotech developing antibody-based immunother…
|
ADAG | KY | Professional, scientific and te… |
|
ADALTA LIMITED
Clinical-stage biotech developing i-body protein therapeuti…
|
1AD | AU | Professional, scientific and te… |
|
Adaptive Biotechnologies Corp
Decodes the adaptive immune system to develop products for …
|
ADPT | US | Professional, scientific and te… |
|
Adeia Inc.
R&D company that licenses IP for the media, entertainment, …
|
ADEA | US | Professional, scientific and te… |
|
Aditxt, Inc.
Acquires, develops, and deploys health technologies to addr…
|
ADTX | US | Professional, scientific and te… |
|
Advanced Biomed Inc.
Develops microfluidic biochip diagnostic systems for precis…
|
ADVB | US | Professional, scientific and te… |
|
Advanced Proteome Therapeutics Corporation
Develops proprietary technology for chemical modification o…
|
APC.H | CA | Professional, scientific and te… |
OSR Holdings, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35169/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35169 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35169 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35169 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35169}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for OSR Holdings, Inc. (id: 35169)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.